Reconceptualizing Vaccine Approaches Across the Development Pipeline

Time: 3:15 pm
day: Day One


  • What opportunities/advantages do mRNA- based vaccines offer against infectious diseases and how to accelerate success?
  • Learning from current pandemic and past infectious diseases for designing more potent vaccines
  • Regulatory standards for saRNA vaccines (revisiting criteria beyond VNT)